US Patent 11643450 Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof
Patent 11643450 was granted and assigned to University of Maryland, Baltimore on May, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11643450 Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.